Search
for

    GlossaryCXCL2 (Macrophage Inflammatory Protein 2)

    small signaling protein that attracts immune cells to inflammation

    CXCL2, also known as Macrophage Inflammatory Protein 2 (MIP-2), is a type of chemokine—a small signaling protein involved in the immune response. It plays a crucial role in attracting neutrophils, a type of white blood cell, to sites of inflammation or injury, thereby aiding in the body's defense mechanisms.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 1000+ results

    Community Join

    3 / 3 results

      community Verteporfin and Microneedling

      in Treatments 4 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 2 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.